Form 4: Neuraxis Director Brian Hannasch Boosts Stake with Significant Stock Purchase

Brian Hannasch, a Director and 10% Owner of Neuraxis, INC, has purchased 355,556 shares of common stock, increasing his total beneficial ownership to 1,131,522 shares.

Summary

• Brian Hannasch, identified as a Director and 10% Owner of Neuraxis, INC (NRX), acquired 355,556 shares of common stock.
• The transaction occurred on July 1, 2025, with shares purchased at a price of $2.25 per share.
• Following this acquisition, Brian Hannasch's total beneficial ownership in Neuraxis, INC stands at 1,131,522 shares of common stock.

Sentiment

Score: 8

Explanation: The sentiment is positive due to a significant stock purchase by a director and 10% owner, indicating strong insider confidence in the company's future.

Positives

• A significant purchase by a Director and 10% Owner signals strong insider confidence in the company's future performance and valuation.
• The increase in beneficial ownership by a key insider aligns the interests of management more closely with those of public shareholders.

Future Outlook

The document does not contain any forward-looking statements or guidance, as it is a factual report of an insider transaction.

Industry Context

This Form 4 filing details an insider transaction, which is a routine disclosure required by the SEC for company officers, directors, and significant shareholders. Such transactions are closely watched by investors as they can provide insights into management's perception of the company's value and prospects, though they do not directly reflect broader industry trends.

Related Party Transactions

• Brian Hannasch, a Director and 10% Owner of Neuraxis, INC, purchased 355,556 shares of the company's common stock, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal, potentially increasing confidence in the company's stock.
• The transaction aligns the interests of a key insider more closely with those of other shareholders.

Key Dates

Keywords

Neuraxis, NRX, insider trading, stock purchase, director, 10% owner, SEC Form 4, common stock, beneficial ownership